0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Viewpoint  | 
Optimizing Adjuvant Chemotherapy and Surgery for Early- and Late-Stage Breast Cancer
Ines Vaz-Luis, MD, MSc; Harold J. Burstein, MD, PhD
JAMA Oncology
Editorial  | 
Atypical Ductal Hyperplasia What Is the Current Risk for Developing Breast Cancer?
Marissa Howard-McNatt, MD
JAMA Oncology
Editorial  | 
Who Benefits From a Tumor Bed Boost After Whole-Breast Radiotherapy?
Laurie W. Cuttino, MD; Charlotte Dai Kubicky, MD, PhD
JAMA Oncology
Original Investigation  | 
Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy
Tehillah S. Menes, MD; Karla Kerlikowske, MD; Jane Lange, PhD; et al.